March 31, 2022

National Platform for Telemedicine: Agenas launches a request for proposals to set up a Public/Private Partnership

Taking advantage of the resources made available under the Next Generation EU Plan, the Italian Government has decided to launch a project for the planning, implementation and delivery of IT services facilitating access to the National Platform for Telemedicine. The overall goal is to enhance the integration between local services providers and the above Platform, as well as to boost telemedicine services on a national scale. To this purpose, the Italian National Agency for Regional Health Services (Agenas – Agenzia Nazionale per i Servizi Sanitari Regionali) has recently launched a request for proposals (avviso esplorativo per una manifestazione di interesse) aiming at exploring the possibility to set up a Public/Private Partnership (a PPP) pursuant to Section 183 of Legislative Decree no. 50/2016 (the Public Procurement Code or the Code). 

The procedure will be a two-step process. In the first stage, interested operators shall file a feasibility project, complete with a financial plan certified by a financial institution, a draft convention to be entered into with Agenas and the details of the services to be rendered. The selected package will form the object of the following step, consisting of a call for tenders aiming at selecting the operator to be appointed as developer of the project. It is worth noting that the entity successfully passing phase 1 shall be entitled with a pre-emption right for the awarding of the concession to be entered into upon conclusion of phase 2 of the procedure. 

The successfull bidder will be entrusted with an up to 8-year convention to be entered into with Agenas, and will receive a total contribution of up to 200 MLN EUR, in terms of non-repayable grant for the implementation of the services to be rendered and yearly fees to be paid by Agenas. 

Deadline for the filing of the initial project package is May 18th, 2022. 

< Back to blog
Welcome to the Portolano Cavallo Life Sciences blog focusing on legal development and key legal issues affecting the life sciences and healthcare industry.
Read more
Our highly-ranked team of professionals will provide news, insights and multidisciplinary commentary on the hottest and most recent regulatory, transactional and contentious aspects of the pharmaceutical, bio-tech, med-tech, food supplement and healthcare world with an eye on its digital transformation and technological developments.

This blog will be a place for focusing on digital health, telemedicine and artificial intelligence, as well as more traditional topics: from the protection of intellectual properties to performance of clinical trials, from the market access to advertising and competition issues, from internal and criminal investigations to M&A and venture capital transactions.

March 20, 2023
Today, Regulation (EU) 2023/607 extending the transitional provisions for the placing on the market and putting into service of certain medical devices and in vitro diagnostic medical device...
January 31, 2023
Clinical trials: Ministry of Health signed off on decrees that (i) reorganize ethics committees and coordinate their activities, (ii) determine the single tariff for the authorization proced...
December 19, 2022
On 13 December 2022, EMA, European Commission and HMA jointly adopted a recommendation paper on the introduction of decentralised elements in the conduct of Clinical Trials in the EU/EEA
September 21, 2022
Payback for medical devices: Decree quantifying the exceeding of the expenditure ceiling for medical devices at national and regional level for the years 2015, 2016, 2017 and 2018 published ...
September 1, 2022
The 2021 annual law for market and competition addressing, as to the healthcare sector, reimbursement of drugs, intermediate distribution, patent linkage and institutional accreditation of p...
Search by...
Follow us on
Follow us on